SearchIP Handbook Blog
Your source for expert commentary on IP management issues. About |
Home > Author Index > FREIRE, Maria FREIRE, Maria
From 1995 to 2001, Dr. Freire directed the Office of Technology Transfer at the NIH, where she was responsible of technology transfer policies and procedures for the Department of Health and Human Services and for patenting and licensing activities at the NIH and the FDA. Dr. Freire is an internationally recognized expert in technology commercialization. She is a member of the NIH Advisory Board for Clinical Research, a Governor of the New York Academy of Sciences, and the Chair of the Working Group for New TB Drugs for the global Stop TB Partnership. Dr. Freire was selected as one of ten Commissioners of the World Health Organization’s Commission on Intellectual Property Rights, Innovation and Public Health (CIPIH) and a member of Time magazine’s Global Health Summit Board of Advisors. Born in Lima, Peru, Dr. Freire trained at the Universidad Peruana Cayetano Heredia. She holds a Ph.D. in biophysics and completed post-graduate studies in immunology and virology at the University of Virginia and the University of Tennessee, respectively, and at the John F. Kennedy School of Government at Harvard University. She has received numerous national and international awards, including the Arthur S. Flemming Award, DHHS Secretary’s Award for Distinguished Service, and the Bayh-Dole Award.
Contributions
|
Get the printed IP Handbook or its Executive Guide.
|
Printer Friendly
Dr. Maria C. Freire is CEO and President of The Global Alliance for TB Drug Development, a position she has held since 2001. During her service, the Alliance has built the largest pipeline of TB drugs in the world, advanced compounds into clinical testing, and pioneered precedent-setting agreements with industry.
Show All Abstracts